1. Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients
   Yong Shen et al, 2015, Emerging Microbes & Infections CrossRef
2. Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1
   Yali Song et al, 2016, Oncotarget CrossRef
3. Oral Bacteria, Virus and Fungi in Saliva and Tissue Samples from Adult Subjects with Oral Squamous Cell Carcinoma: An Umbrella Review
   Federica Di Spirito et al, 2023, Cancers CrossRef
4. Cross-talk between Epstein-Barr virus and microenvironment in the pathogenesis of lymphomas
   Riccardo Dolcetti, 2015, Seminars in Cancer Biology CrossRef
5. Epstein-Barr Virus Infection Induces Indoleamine 2,3-Dioxygenase Expression in Human Monocyte-Derived Macrophages through p38/Mitogen-Activated Protein Kinase and NF-κB Pathways: Impairment in T Cell Functions
   Wan-li Liu et al, 2014, Journal of Virology CrossRef
6. Significant role of macrophages in human cancers associated with Epstein-Barr virus (Review)
   MISUZU SHIMAKAGE, 2014, Oncology Reports CrossRef
7. Epstein-Barr virus infection and oral squamous cell carcinoma risk: A meta-analysis
   Yangyang She et al, 2017, PLOS ONE CrossRef
8. Tumor-promoting myeloid cells in the pathogenesis of human oncoviruses: potential targets for immunotherapy
   Azin Aghamajidi et al, 2022, Cancer Cell International CrossRef
9. Prognostic role of tumour-associated macrophages and regulatory T cells in EBV-positive and EBV-negative nasopharyngeal carcinoma
   Marc L Ooft et al, 2018, Journal of Clinical Pathology CrossRef
10. Chitinase 3 like-1 activates the Akt pathway, inducing NF-κB-dependent release of pro-inflammatory cytokines and promoting the proliferative ability in nasopharyngeal carcinoma cells
    Dajun Li et al, 2024, Cytokine CrossRef